16-15396164-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The ENST00000396385.4(MPV17L):c.267C>A(p.Asp89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,398,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000396385.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPV17L | NM_001128423.2 | c.267C>A | p.Asp89Glu | missense_variant | 1/4 | ENST00000396385.4 | NP_001121895.1 | |
MPV17L-BMERB1 | NM_001414674.1 | c.267C>A | p.Asp89Glu | missense_variant | 1/6 | NP_001401603.1 | ||
MPV17L | NM_173803.4 | c.267C>A | p.Asp89Glu | missense_variant | 1/3 | NP_776164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPV17L | ENST00000396385.4 | c.267C>A | p.Asp89Glu | missense_variant | 1/4 | 1 | NM_001128423.2 | ENSP00000379669.3 | ||
ENSG00000261130 | ENST00000568766.1 | c.267C>A | p.Asp89Glu | missense_variant | 1/2 | 2 | ENSP00000454340.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1398168Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 689980
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2024 | The c.267C>A (p.D89E) alteration is located in exon 1 (coding exon 1) of the MPV17L gene. This alteration results from a C to A substitution at nucleotide position 267, causing the aspartic acid (D) at amino acid position 89 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.